» Articles » PMID: 20110438

Plerixafor-moblized Stem Cells Alone Are Capable of Inducing Early Engraftment Across the MHC-haploidentical Canine Barrier

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2010 Jan 30
PMID 20110438
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Humbert O, Chan F, Rajawat Y, Torgerson T, Burtner C, Hubbard N Blood Adv. 2018; 2(9):987-999.

PMID: 29720491 PMC: 5942001. DOI: 10.1182/bloodadvances.2018016451.


Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.

Chang J, Graves S, Butts-Miwongtum T, Sale G, Storb R, Mathes D Transplantation. 2016; 100(12):e120-e127.

PMID: 27861292 PMC: 5453180. DOI: 10.1097/TP.0000000000001496.


Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers.

Chang Y, Huang X Bone Marrow Transplant. 2014; 49(7):873-9.

PMID: 24566712 DOI: 10.1038/bmt.2014.19.


Physiology and pharmacology of plerixafor.

Fricker S Transfus Med Hemother. 2013; 40(4):237-45.

PMID: 24179472 PMC: 3776399. DOI: 10.1159/000354132.


Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.

Chen Y, Fukuda T, Thakar M, Kornblit B, Storer B, Santos E Cytotherapy. 2011; 13(10):1269-80.

PMID: 21846291 PMC: 3195840. DOI: 10.3109/14653249.2011.586997.

References
1.
Devine S, Vij R, Rettig M, Todt L, McGlauchlen K, Fisher N . Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Blood. 2008; 112(4):990-8. DOI: 10.1182/blood-2007-12-130179. View

2.
McSweeney P, Rouleau K, Wallace P, Bruno B, Andrews R, Sandmaier B . Characterization of monoclonal antibodies that recognize canine CD34. Blood. 1998; 91(6):1977-86. View

3.
Donahue R, Jin P, Bonifacino A, Metzger M, Ren J, Wang E . Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures. Blood. 2009; 114(12):2530-41. PMC: 2746476. DOI: 10.1182/blood-2009-04-214403. View

4.
Burroughs L, Mielcarek M, Little M, Bridger G, MacFarland R, Fricker S . Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model. Blood. 2005; 106(12):4002-8. PMC: 1895108. DOI: 10.1182/blood-2005-05-1937. View

5.
Fukuda T, Kerbauy F, Gooley T, Santos E, Storb R, Sandmaier B . Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model. Transplantation. 2006; 82(3):332-9. DOI: 10.1097/01.tp.0000228908.10775.b0. View